Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California
- PMID: 15382072
- DOI: 10.1002/ijc.20434
Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California
Abstract
Perineal talc use has been suggested as a possible risk factor for ovarian cancer based on its structural similarity to asbestos, a known human carcinogen. A population-based epidemiologic case-control study of epithelial ovarian cancer (EOC) was conducted in 22 counties of Central California that comprise the reporting area for 2 regional cancer registries. Telephone interviews were conducted with 256 cases diagnosed in the years 2000-2001 and 1,122 controls frequency-matched on age and ethnicity. The interview obtained information on demographic factors, menstrual and reproductive experience, exogenous hormone use, surgical history and family history of cancer. Questions on perineal talc use included frequency of use, duration of use and specific years when talc was used. Multivariate-adjusted odds ratio (OR) and 95% confidence intervals (CI) were derived from unconditional logistic regression. The OR for ever use of talc was 1.37 (CI = 1.02-1.85) compared to never users. However, no dose response association was found. Tubal ligation (TL) modified the effect of talc on EOC such that women with TL had an OR of 0.88 (CI = 0.46-1.68) associated with perineal talc use, whereas women with no TL had an OR of 1.54 (CI = 1.10-2.16). Talc use and EOC risk was highest in women with serous invasive tumors (OR = 1.77; CI = 1.12-2.81). This study provides some support for the hypothesis that perineal talc use is associated with an increased risk of EOC.
Similar articles
-
Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.J Natl Cancer Inst. 2002 Apr 3;94(7):497-504. doi: 10.1093/jnci/94.7.497. J Natl Cancer Inst. 2002. PMID: 11929950 Clinical Trial.
-
Perineal exposure to talc and ovarian cancer risk.Obstet Gynecol. 1992 Jul;80(1):19-26. Obstet Gynecol. 1992. PMID: 1603491 Review.
-
Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.Epidemiology. 2018 Jan;29(1):41-49. doi: 10.1097/EDE.0000000000000745. Epidemiology. 2018. PMID: 28863045 Review.
-
Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.Obstet Gynecol. 1999 Mar;93(3):372-6. doi: 10.1016/s0029-7844(98)00439-6. Obstet Gynecol. 1999. PMID: 10074982
-
Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.Int J Cancer. 2008 Jan 1;122(1):170-6. doi: 10.1002/ijc.23017. Int J Cancer. 2008. PMID: 17721999
Cited by
-
Douching, Talc Use, and Risk of Ovarian Cancer.Epidemiology. 2016 Nov;27(6):797-802. doi: 10.1097/EDE.0000000000000528. Epidemiology. 2016. PMID: 27327020 Free PMC article.
-
Perineal talc use and ovarian cancer: a critical review.Eur J Cancer Prev. 2008 Apr;17(2):139-46. doi: 10.1097/CEJ.0b013e32811080ef. Eur J Cancer Prev. 2008. PMID: 18287871 Free PMC article. Review.
-
Current understanding of risk factors for ovarian cancer.Curr Treat Options Oncol. 2009 Apr;10(1-2):67-81. doi: 10.1007/s11864-009-0108-2. Epub 2009 Jul 15. Curr Treat Options Oncol. 2009. PMID: 19603272 Review.
-
Perineal use of talcum powder and endometrial cancer risk.Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1269-75. doi: 10.1158/1055-9965.EPI-09-1221. Epub 2010 Apr 20. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20406962 Free PMC article.
-
Risk factors for epithelial ovarian cancer by histologic subtype.Am J Epidemiol. 2010 Jan 1;171(1):45-53. doi: 10.1093/aje/kwp314. Epub 2009 Nov 12. Am J Epidemiol. 2010. PMID: 19910378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical